FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application from Aurobindo Pharma Limited for rivastigmine tartrate (generic), authorizing its use for treating mild to moderate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine tartrate (rivastigmine tartrate)

Snippet

SUPPL AP for RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)